세계의 임상 검사 서비스 시장 : 산업 분석, 시장 규모, 점유율, 성장, 동향 및 예측(2025-2035년)

Clinical Laboratory Services Market- Scope of Report

TMR's report on the global Clinical Laboratory Services Marketstudies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global Clinical Laboratory Services Marketfor the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Clinical Laboratory Services Marketfrom 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the two-wheeler navigation display market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global two-wheeler navigation display market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global two-wheeler navigation display market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global two-wheeler navigation display market.

The report delves into the competitive landscape of the global two-wheeler navigation display market. Key players operating in the global Clinical Laboratory Services Markethave been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Clinical Laboratory Services Marketprofiled in this report.

Key Questions Answered in Global Clinical Laboratory Services MarketReport:

• What is the sales/revenue generated by apheresis across all regions during the forecast period?
• What are the opportunities in the global two-wheeler navigation display market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Clinical Laboratory Services Market- Research Objectives and Research Approach

The comprehensive report on the global Clinical Laboratory Services Marketbegins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Clinical Laboratory Services Marketin terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global two-wheeler navigation display market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Clinical Laboratory Services Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Clinical Laboratory Services Market Analysis and Forecasts, 2020 to 2035
  • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

• 5.1. Healthcare Expenditure across Key Regions / Countries
• 5.2. List of Clinical Laboratory Service Providers across Key Regions / Countries
• 5.3. PORTER's Five Forces Analysis
• 5.4. PESTEL Analysis
• 5.5. Value Chain Analysis
• 5.6. Key Purchase Metrics for End-users
• 5.7. Go-to-Market Strategy for New Market Entrants
• 5.8. Key Industry Events (Partnerships, Collaborations, Product approvals, mergers & acquisitions)
• 5.9. Benchmarking of Services Offered by the Leading Competitors

6. Global Clinical Laboratory Services Market Analysis and Forecasts, By Test Type

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Test Type, 2020 to 2035
  • 6.3.1. Clinical Chemistry Testing
    • 6.3.1.1. Routine Chemistry Testing
    • 6.3.1.2. Endocrinology Chemistry Testing
    • 6.3.1.3. Therapeutic Drug Monitoring Testing
    • 6.3.1.4. Specialized Chemistry Testing
    • 6.3.1.5. Other Clinical Chemistry Testing
  • 6.3.2. Medical Microbiology Testing
    • 6.3.2.1. Infectious Disease Testing
    • 6.3.2.2. Transplant Diagnostic Testing
    • 6.3.2.3. Other Microbiology Testing
  • 6.3.3. Hematology Testing
    • 6.3.3.1. Routine Blood Testing
    • 6.3.3.2. Coagulation Testing
    • 6.3.3.3. Specialized Hematology Testing
  • 6.3.4. Immunology Testing
  • 6.3.5. Genetic Testing
  • 6.3.6. Cytology Testing
  • 6.3.7. Drug of Abuse Testing
  • 6.3.8. Others
• 6.4. Market Attractiveness By Test Type

7. Global Clinical Laboratory Services Market Analysis and Forecasts, By Technology

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Technology, 2020 to 2035
  • 7.3.1. PCR
  • 7.3.2. Mass Spectrometry
  • 7.3.3. Next-Generation Sequencing
  • 7.3.4. Immunoassay
  • 7.3.5. Chromatography
  • 7.3.6. Point-of-Care Testing
  • 7.3.7. Others
• 7.4. Market Attractiveness By Technology

8. Global Clinical Laboratory Services Market Analysis and Forecasts, By Application

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By Application, 2020 to 2035
  • 8.3.1. Drug Discovery and Development
  • 8.3.2. Preclinical and Clinical Trial
  • 8.3.3. Bioanalytical and Lab Chemistry
  • 8.3.4. Toxicology Testing
  • 8.3.5. Others
• 8.4. Market Attractiveness By Application

9. Global Clinical Laboratory Services Market Analysis and Forecasts, By Type of Service Provider

• 9.1. Introduction & Definition
• 9.2. Key Findings / Developments
• 9.3. Market Value Forecast By Type of Service Provider, 2020 to 2035
  • 9.3.1. Hospital-based Laboratories
  • 9.3.2. Standalone Laboratories
  • 9.3.3. Clinic-based Laboratories
• 9.4. Market Attractiveness By Type of Service Provider

10. Global Clinical Laboratory Services Market Analysis and Forecasts, By Region

• 10.1. Key Findings
• 10.2. Market Value Forecast By Region
  • 10.2.1. North America
  • 10.2.2. Europe
  • 10.2.3. Asia Pacific
  • 10.2.4. Latin America
  • 10.2.5. Middle East & Africa
• 10.3. Market Attractiveness By Region

11. North America Clinical Laboratory Services Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast By Test Type, 2020 to 2035
  • 11.2.1. Clinical Chemistry Testing
    • 11.2.1.1. Routine Chemistry Testing
    • 11.2.1.2. Endocrinology Chemistry Testing
    • 11.2.1.3. Therapeutic Drug Monitoring Testing
    • 11.2.1.4. Specialized Chemistry Testing
    • 11.2.1.5. Other Clinical Chemistry Testing
  • 11.2.2. Medical Microbiology Testing
    • 11.2.2.1. Infectious Disease Testing
    • 11.2.2.2. Transplant Diagnostic Testing
    • 11.2.2.3. Other Microbiology Testing
  • 11.2.3. Hematology Testing
    • 11.2.3.1. Routine Blood Testing
    • 11.2.3.2. Coagulation Testing
    • 11.2.3.3. Specialized Hematology Testing
  • 11.2.4. Immunology Testing
  • 11.2.5. Genetic Testing
  • 11.2.6. Cytology Testing
  • 11.2.7. Drug of Abuse Testing
  • 11.2.8. Others
• 11.3. Market Value Forecast By Technology, 2020 to 2035
  • 11.3.1. PCR
  • 11.3.2. Mass Spectrometry
  • 11.3.3. Next-Generation Sequencing
  • 11.3.4. Immunoassay
  • 11.3.5. Chromatography
  • 11.3.6. Point-of-Care Testing
  • 11.3.7. Others
• 11.4. Market Value Forecast By Application, 2020 to 2035
  • 11.4.1. Drug Discovery and Development
  • 11.4.2. Preclinical and Clinical Trial
  • 11.4.3. Bioanalytical and Lab Chemistry
  • 11.4.4. Toxicology Testing
  • 11.4.5. Others
• 11.5. Market Value Forecast By Type of Service Provider, 2020 to 2035
  • 11.5.1. Hospital-based Laboratories
  • 11.5.2. Standalone Laboratories
  • 11.5.3. Clinic-based Laboratories
• 11.6. Market Value Forecast By Country, 2020 to 2035
  • 11.6.1. U.S.
  • 11.6.2. Canada
• 11.7. Market Attractiveness Analysis
  • 11.7.1. By Test Type
  • 11.7.2. By Technology
  • 11.7.3. By Application
  • 11.7.4. By Type of Service Provider
  • 11.7.5. By Country

12. Europe Clinical Laboratory Services Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast By Test Type, 2020 to 2035
  • 12.2.1. Clinical Chemistry Testing
    • 12.2.1.1. Routine Chemistry Testing
    • 12.2.1.2. Endocrinology Chemistry Testing
    • 12.2.1.3. Therapeutic Drug Monitoring Testing
    • 12.2.1.4. Specialized Chemistry Testing
    • 12.2.1.5. Other Clinical Chemistry Testing
  • 12.2.2. Medical Microbiology Testing
    • 12.2.2.1. Infectious Disease Testing
    • 12.2.2.2. Transplant Diagnostic Testing
    • 12.2.2.3. Other Microbiology Testing
  • 12.2.3. Hematology Testing
    • 12.2.3.1. Routine Blood Testing
    • 12.2.3.2. Coagulation Testing
    • 12.2.3.3. Specialized Hematology Testing
  • 12.2.4. Immunology Testing
  • 12.2.5. Genetic Testing
  • 12.2.6. Cytology Testing
  • 12.2.7. Drug of Abuse Testing
  • 12.2.8. Others
• 12.3. Market Value Forecast By Technology, 2020 to 2035
  • 12.3.1. PCR
  • 12.3.2. Mass Spectrometry
  • 12.3.3. Next-Generation Sequencing
  • 12.3.4. Immunoassay
  • 12.3.5. Chromatography
  • 12.3.6. Point-of-Care Testing
  • 12.3.7. Others
• 12.4. Market Value Forecast By Application, 2020 to 2035
  • 12.4.1. Drug Discovery and Development
  • 12.4.2. Preclinical and Clinical Trial
  • 12.4.3. Bioanalytical and Lab Chemistry
  • 12.4.4. Toxicology Testing
  • 12.4.5. Others
• 12.5. Market Value Forecast By Type of Service Provider, 2020 to 2035
  • 12.5.1. Hospital-based Laboratories
  • 12.5.2. Standalone Laboratories
  • 12.5.3. Clinic-based Laboratories
• 12.6. Market Value Forecast By Country / Sub-region, 2020 to 2035
  • 12.6.1. Germany
  • 12.6.2. UK
  • 12.6.3. France
  • 12.6.4. Italy
  • 12.6.5. Spain
  • 12.6.6. Switzerland
  • 12.6.7. The Netherlands
  • 12.6.8. Rest of Europe
• 12.7. Market Attractiveness Analysis
  • 12.7.1. By Test Type
  • 12.7.2. By Technology
  • 12.7.3. By Application
  • 12.7.4. By Type of Service Provider
  • 12.7.5. By Country / Sub-region

13. Asia Pacific Clinical Laboratory Services Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Test Type, 2020 to 2035
  • 13.2.1. Clinical Chemistry Testing
    • 13.2.1.1. Routine Chemistry Testing
    • 13.2.1.2. Endocrinology Chemistry Testing
    • 13.2.1.3. Therapeutic Drug Monitoring Testing
    • 13.2.1.4. Specialized Chemistry Testing
    • 13.2.1.5. Other Clinical Chemistry Testing
  • 13.2.2. Medical Microbiology Testing
    • 13.2.2.1. Infectious Disease Testing
    • 13.2.2.2. Transplant Diagnostic Testing
    • 13.2.2.3. Other Microbiology Testing
  • 13.2.3. Hematology Testing
    • 13.2.3.1. Routine Blood Testing
    • 13.2.3.2. Coagulation Testing
    • 13.2.3.3. Specialized Hematology Testing
  • 13.2.4. Immunology Testing
  • 13.2.5. Genetic Testing
  • 13.2.6. Cytology Testing
  • 13.2.7. Drug of Abuse Testing
  • 13.2.8. Others
• 13.3. Market Value Forecast By Technology, 2020 to 2035
  • 13.3.1. PCR
  • 13.3.2. Mass Spectrometry
  • 13.3.3. Next-Generation Sequencing
  • 13.3.4. Immunoassay
  • 13.3.5. Chromatography
  • 13.3.6. Point-of-Care Testing
  • 13.3.7. Others
• 13.4. Market Value Forecast By Application, 2020 to 2035
  • 13.4.1. Drug Discovery and Development
  • 13.4.2. Preclinical and Clinical Trial
  • 13.4.3. Bioanalytical and Lab Chemistry
  • 13.4.4. Toxicology Testing
  • 13.4.5. Others
• 13.5. Market Value Forecast By Type of Service Provider, 2020 to 2035
  • 13.5.1. Hospital-based Laboratories
  • 13.5.2. Standalone Laboratories
  • 13.5.3. Clinic-based Laboratories
• 13.6. Market Value Forecast By Country / Sub-region, 2020 to 2035
  • 13.6.1. China
  • 13.6.2. India
  • 13.6.3. Japan
  • 13.6.4. South Korea
  • 13.6.5. Australia & New Zealand
  • 13.6.6. Rest of Asia Pacific
• 13.7. Market Attractiveness Analysis
  • 13.7.1. By Test Type
  • 13.7.2. By Technology
  • 13.7.3. By Application
  • 13.7.4. By Type of Service Provider
  • 13.7.5. By Country / Sub-region

14. Latin America Clinical Laboratory Services Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Test Type, 2020 to 2035
  • 14.2.1. Clinical Chemistry Testing
    • 14.2.1.1. Routine Chemistry Testing
    • 14.2.1.2. Endocrinology Chemistry Testing
    • 14.2.1.3. Therapeutic Drug Monitoring Testing
    • 14.2.1.4. Specialized Chemistry Testing
    • 14.2.1.5. Other Clinical Chemistry Testing
  • 14.2.2. Medical Microbiology Testing
    • 14.2.2.1. Infectious Disease Testing
    • 14.2.2.2. Transplant Diagnostic Testing
    • 14.2.2.3. Other Microbiology Testing
  • 14.2.3. Hematology Testing
    • 14.2.3.1. Routine Blood Testing
    • 14.2.3.2. Coagulation Testing
    • 14.2.3.3. Specialized Hematology Testing
  • 14.2.4. Immunology Testing
  • 14.2.5. Genetic Testing
  • 14.2.6. Cytology Testing
  • 14.2.7. Drug of Abuse Testing
  • 14.2.8. Others
• 14.3. Market Value Forecast By Technology, 2020 to 2035
  • 14.3.1. PCR
  • 14.3.2. Mass Spectrometry
  • 14.3.3. Next-Generation Sequencing
  • 14.3.4. Immunoassay
  • 14.3.5. Chromatography
  • 14.3.6. Point-of-Care Testing
  • 14.3.7. Others
• 14.4. Market Value Forecast By Application, 2020 to 2035
  • 14.4.1. Drug Discovery and Development
  • 14.4.2. Preclinical and Clinical Trial
  • 14.4.3. Bioanalytical and Lab Chemistry
  • 14.4.4. Toxicology Testing
  • 14.4.5. Others
• 14.5. Market Value Forecast By Type of Service Provider, 2020 to 2035
  • 14.5.1. Hospital-based Laboratories
  • 14.5.2. Standalone Laboratories
  • 14.5.3. Clinic-based Laboratories
• 14.6. Market Value Forecast By Country / Sub-region, 2020 to 2035
  • 14.6.1. Brazil
  • 14.6.2. Mexico
  • 14.6.3. Argentina
  • 14.6.4. Rest of Latin America
• 14.7. Market Attractiveness Analysis
  • 14.7.1. By Test Type
  • 14.7.2. By Technology
  • 14.7.3. By Application
  • 14.7.4. By Type of Service Provider
  • 14.7.5. By Country / Sub-region

15. Middle East & Africa Clinical Laboratory Services Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast By Test Type, 2020 to 2035
  • 15.2.1. Clinical Chemistry Testing
    • 15.2.1.1. Routine Chemistry Testing
    • 15.2.1.2. Endocrinology Chemistry Testing
    • 15.2.1.3. Therapeutic Drug Monitoring Testing
    • 15.2.1.4. Specialized Chemistry Testing
    • 15.2.1.5. Other Clinical Chemistry Testing
  • 15.2.2. Medical Microbiology Testing
    • 15.2.2.1. Infectious Disease Testing
    • 15.2.2.2. Transplant Diagnostic Testing
    • 15.2.2.3. Other Microbiology Testing
  • 15.2.3. Hematology Testing
    • 15.2.3.1. Routine Blood Testing
    • 15.2.3.2. Coagulation Testing
    • 15.2.3.3. Specialized Hematology Testing
  • 15.2.4. Immunology Testing
  • 15.2.5. Genetic Testing
  • 15.2.6. Cytology Testing
  • 15.2.7. Drug of Abuse Testing
  • 15.2.8. Others
• 15.3. Market Value Forecast By Technology, 2020 to 2035
  • 15.3.1. PCR
  • 15.3.2. Mass Spectrometry
  • 15.3.3. Next-Generation Sequencing
  • 15.3.4. Immunoassay
  • 15.3.5. Chromatography
  • 15.3.6. Point-of-Care Testing
  • 15.3.7. Others
• 15.4. Market Value Forecast By Application, 2020 to 2035
  • 15.4.1. Drug Discovery and Development
  • 15.4.2. Preclinical and Clinical Trial
  • 15.4.3. Bioanalytical and Lab Chemistry
  • 15.4.4. Toxicology Testing
  • 15.4.5. Others
• 15.5. Market Value Forecast By Type of Service Provider, 2020 to 2035
  • 15.5.1. Hospital-based Laboratories
  • 15.5.2. Standalone Laboratories
  • 15.5.3. Clinic-based Laboratories
• 15.6. Market Value Forecast By Country / Sub-region, 2020 to 2035
  • 15.6.1. GCC Countries
  • 15.6.2. South Africa
  • 15.6.3. Rest of Middle East & Africa
• 15.7. Market Attractiveness Analysis
  • 15.7.1. By Test Type
  • 15.7.2. By Technology
  • 15.7.3. By Application
  • 15.7.4. By Type of Service Provider
  • 15.7.5. By Country / Sub-region

16. Competition Landscape

• 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 16.2. Market Share Analysis By Company (2024)
• 16.3. Company Profiles
  • 16.3.1. Laboratory Corporation of America (LabCorp)
    • 16.3.1.1. Company Overview
    • 16.3.1.2. Financial Overview
    • 16.3.1.3. Product Portfolio
    • 16.3.1.4. Business Strategies
    • 16.3.1.5. Recent Developments
  • 16.3.2. BioReference Health, LLC
    • 16.3.2.1. Company Overview
    • 16.3.2.2. Financial Overview
    • 16.3.2.3. Product Portfolio
    • 16.3.2.4. Business Strategies
    • 16.3.2.5. Recent Developments
  • 16.3.3. PPD (Thermo Fisher Scientific Inc.)
    • 16.3.3.1. Company Overview
    • 16.3.3.2. Financial Overview
    • 16.3.3.3. Product Portfolio
    • 16.3.3.4. Business Strategies
    • 16.3.3.5. Recent Developments
  • 16.3.4. Myriad Genetics, Inc.
    • 16.3.4.1. Company Overview
    • 16.3.4.2. Financial Overview
    • 16.3.4.3. Product Portfolio
    • 16.3.4.4. Business Strategies
    • 16.3.4.5. Recent Developments
  • 16.3.5. NeoGenomics Laboratories.
    • 16.3.5.1. Company Overview
    • 16.3.5.2. Financial Overview
    • 16.3.5.3. Product Portfolio
    • 16.3.5.4. Business Strategies
    • 16.3.5.5. Recent Developments
  • 16.3.6. Quest Diagnostics Incorporated
    • 16.3.6.1. Company Overview
    • 16.3.6.2. Financial Overview
    • 16.3.6.3. Product Portfolio
    • 16.3.6.4. Business Strategies
    • 16.3.6.5. Recent Developments
  • 16.3.7. Siemens Healthcare Private Limited
    • 16.3.7.1. Company Overview
    • 16.3.7.2. Financial Overview
    • 16.3.7.3. Product Portfolio
    • 16.3.7.4. Business Strategies
    • 16.3.7.5. Recent Developments
  • 16.3.8. Sonic Healthcare Limited
    • 16.3.8.1. Company Overview
    • 16.3.8.2. Financial Overview
    • 16.3.8.3. Product Portfolio
    • 16.3.8.4. Business Strategies
    • 16.3.8.5. Recent Developments
  • 16.3.9. SYNLAB International GmbH
    • 16.3.9.1. Company Overview
    • 16.3.9.2. Financial Overview
    • 16.3.9.3. Product Portfolio
    • 16.3.9.4. Business Strategies
    • 16.3.9.5. Recent Developments
  • 16.3.10. Eurofins Scientific
    • 16.3.10.1. Company Overview
    • 16.3.10.2. Financial Overview
    • 16.3.10.3. Product Portfolio
    • 16.3.10.4. Business Strategies
    • 16.3.10.5. Recent Developments
  • 16.3.11. Charles River Laboratories
    • 16.3.11.1. Company Overview
    • 16.3.11.2. Financial Overview
    • 16.3.11.3. Product Portfolio
    • 16.3.11.4. Business Strategies
    • 16.3.11.5. Recent Developments
  • 16.3.12. Mayo Clinic Laboratories
    • 16.3.12.1. Company Overview
    • 16.3.12.2. Financial Overview
    • 16.3.12.3. Product Portfolio
    • 16.3.12.4. Business Strategies
    • 16.3.12.5. Recent Developments
  • 16.3.13. UNILABS
    • 16.3.13.1. Company Overview
    • 16.3.13.2. Financial Overview
    • 16.3.13.3. Product Portfolio
    • 16.3.13.4. Business Strategies
    • 16.3.13.5. Recent Developments
  • 16.3.14. Metropolis Healthcare
    • 16.3.14.1. Company Overview
    • 16.3.14.2. Financial Overview
    • 16.3.14.3. Product Portfolio
    • 16.3.14.4. Business Strategies
    • 16.3.14.5. Recent Developments
  • 16.3.15. H.U. Group Holdings, Inc.
    • 16.3.15.1. Company Overview
    • 16.3.15.2. Financial Overview
    • 16.3.15.3. Product Portfolio
    • 16.3.15.4. Business Strategies
    • 16.3.15.5. Recent Developments